The Newest Treatments for Addiction: Innovations in Recovery and Rehabilitation

Addiction continues to be a pressing global health issue, affecting millions across various demographics. While traditional treatment methods such as 12-step programs, cognitive behavioral therapy (CBT), and medication-assisted treatment (MAT) have long been...

Ketamine, Esketamine and Depression

In October 2019, the U.S. Food and Drug Administration (FDA) approved esketamine, a substance chemicallyrelated to the party drug ketamine, as a nasal spray to treat depression (Bahr, 2019). The effectiveness of ketamine for depression was first shown in studies in...